dimyristoylphosphatidylcholine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4651 | 18656-38-7 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A synthetic phospholipid used in liposomes and lipid bilayers for the study of biological membranes.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| May 31, 2002 | FDA | IMCOR PHARMS CO |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Chills | 63.01 | 53.89 | 26 | 423 | 160208 | 79583731 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D007202 | Indicators and Reagents |
| CHEBI has role | CHEBI:59132 | antigens |
| CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 0.51 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| N0000168630 | NUI |
| C0012456 | UMLSCUI |
| CHEBI:241349 | CHEBI |
| CHEMBL451503 | ChEMBL_ID |
| 5459377 | PUBCHEM_CID |
| DB11283 | DRUGBANK_ID |
| D004134 | MESH_DESCRIPTOR_UI |
| 1362902 | RXNORM |
| CHEMBL1201501 | ChEMBL_ID |
| U86ZGC74V5 | UNII |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| ABELCET | HUMAN PRESCRIPTION DRUG LABEL | 3 | 57665-101 | INJECTION | 3.40 mg | INTRAVENOUS | NDA | 20 sections |
| ABELCET | HUMAN PRESCRIPTION DRUG LABEL | 3 | 57665-101 | INJECTION | 3.40 mg | INTRAVENOUS | NDA | 20 sections |